STOP
After an initial diagnosis, there is a lifelong risk of breast cancer returning.
Around 1 in 3 breast cancers recur after initial treatment.
This is why STOP is a key focus of our Pink Horizon Research Strategy.
You have returned to the top of the page.
After an initial diagnosis, there is a lifelong risk of breast cancer returning.
Around 1 in 3 breast cancers recur after initial treatment.
This is why STOP is a key focus of our Pink Horizon Research Strategy.